TipRanks
Northwest Biotherapeutics (NWBO)
OTHER OTC:NWBO

Northwest Biotherapeutics (NWBO) Revenue

550 Followers

Northwest Biotherapeutics Revenue

Northwest Biotherapeutics had a revenue of 807.00K in the quarter ending Jun 30, 2026, with 63.36%. This bring the company's revenue in the last twelve months to 2.17M, Decreased 45.16%. In the fiscal year ending Dec 31, 2025, Northwest Biotherapeutics had annual revenue of 1.38M with -0.29% growth.
Revenue (ttm)
2.17M
Revenue Growth
98.63%
P/S Ratio
190.24
Revenue/Employee
$13,124
Employees
105
Market Cap
$262.16M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
1.38M-4.00K-0.29%
Dec 31, 2024
1.38M-550.00K-28.47%
Dec 31, 2023
1.93M249.00K+14.80%
Dec 31, 2022
1.68M678.00K+67.46%
Dec 31, 2021
1.00M-286.00K-22.15%
Dec 31, 2020
1.29M-1.12M-46.43%
Dec 31, 2019
2.41M2.00M+484.95%
Dec 31, 2018
412.00K76.00K+22.62%
Dec 31, 2017
336.00K――